Angiogenesis and Atherosclerosis

44 Angiogenesis and Atherosclerosis



Revascularization via coronary artery bypass surgery and percutaneous coronary interventions remains the definitive therapy for patients with refractory ischemic heart disease, particularly when accompanied by left ventricular (LV) dysfunction. Bypass surgery in particular reduces mortality in patients with multivessel coronary artery disease and LV dysfunction. However, the surgery itself is invasive and is associated with significant mortality and morbidity. In addition, many patients are poor candidates for bypass based on their coronary anatomy, coexisting conditions, or the severity of their heart failure. Likewise, anatomic complications may make percutaneous coronary interventions such as balloon angioplasty and stent implantation a poor choice for many of these patients. Thus, there is a need for an alternative means of revascularization. The identification of endogenous pathways that regulate angiogenesis—the growth of new blood vessels from existing vessels—has fostered the intriguing hypothesis that if angiogenesis could be promoted in a controlled manner, recently elucidated, endogenous pathways could be stimulated to augment blood vessel formation and revascularize tissues in myocardial ischemic zones.



Mechanisms of Angiogenesis


Angiogenesis occurs by the budding of new blood vessels from existing vessels (Fig. 44-1). Inflammation and hypoxia are the two major stimuli for new vessel growth. Hypoxia regulates angiogenesis predominantly by activating a transcription factor, hypoxia-inducible factor-1, which in turn activates the angiogenesis gene expression cascade. Inflammation stimulates angiogenesis mainly by the secretion of inflammatory cytokines derived primarily from macrophages. In either event, the result is production of vascular endothelial growth factor (VEGF) and other potent angiogenic peptides. VEGF interacts with specific receptors on endothelial cells that, in turn, activate pathways to break down the extracellular matrix and stimulate proliferation and migration toward an angiogenic stimulus and recruitment of pericytes and smooth muscle cells to establish the three-dimensional structure of a blood vessel. After making appropriate connections with the vascular system, the newly formed vessel is capable of maintaining blood flow and providing oxygen to the tissue in need.



Angiogenesis occurs in numerous circumstances, some of which are necessary for normal development and organ function. In other circumstances, angiogenesis is a maladaptive response to local injury or stress. During development, the formation of every organ system is dependent on angiogenic events; in fact, the cardiovascular system is the first organ system to function during embryogenesis. In adult females, the menstrual cycle is dependent on cyclic angiogenesis that is stimulated in part by reproductive hormones. Beyond this, however, most angiogenesis in adults occurs in pathologic conditions or as a response to injury. Tumor growth and metastasis, diabetic vascular disease (including retinopathy), inflammatory arthritides, and wound healing are some of the processes that depend on angiogenesis. In addition, the invasion of ischemic tissues with new capillaries and the development of a collateral circulation to supply occluded vessels, as may occur in chronic obstructive coronary disease, are angiogenic processes.


Jun 12, 2016 | Posted by in CARDIOLOGY | Comments Off on Angiogenesis and Atherosclerosis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access